4
Changes in Ownership
FENNEC PHARMACEUTICALS INC. Filed Acc 0001468308-26-000006
CHIEF FINANCIAL OFFICER acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Andrade Robert CHIEF FINANCIAL OFFICER | 2026-01-15 | Option exercise | +10,000 | $2.45 | $24,500 | 201,100 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Andrade Robert CHIEF FINANCIAL OFFICER | 2026-01-15 | Option exercise · Stock Options | −10,000 | $2.45 | $24,500 | 826,567 | D: show line 2 in the form |
Loading xslF345X05/form4-01152026_040101.xml…